Sponsor: Rep. Sorensen, Eric (D-IL)2 cosponsorsIntroduced May 19, 2026
✆
In plain English
H.R. 8908 authorizes the FDA to deny petitions submitted to the agency when the primary purpose of the petition is to delay approval of a drug or medical product. The bill was introduced by Rep. Eric Sorensen (D-IL) on May 19, 2026, and was referred to the House Committee on Energy and Commerce.
What’s in the bill (2 sections)
Sec. 2. Denial of petitions whose primary purpose is to delay approval
One email when they vote against their own party. Nothing else.
Nonpartisan · Unsubscribe in one click · We never sell your address
Track this bill
Get an alert when it moves to the next stage or gets a vote.
Share
Embed this tracker on your site
Paste this HTML into your blog post or website to show a live tracker for this bill.
The embedded card updates automatically as the bill progresses. Preview →
See something wrong on this page? Tell us what looks incorrect and what it should be — we’ll investigate and correct it.
Report incorrect information
Every figure on this site is supposed to trace back to an official source. If something
here is wrong, telling me is the fastest way it gets fixed — and corrections are
published.